This central mechanism has prompted researchers to investigate whether tirzepatide might influence other reward-driven behaviors, including substance use and addiction

Based on analysis of employer experiences, vendor data, and expert interviews, PHTI outlines five key recommendations for employers: Establish clear, clinically driven eligibility pathways for GLP-1 coverage Require participation in behavior, nutrition, or lifestyle change programs as a condition of coverage Provide structured support for employees who choose to taper or discontinue GLP-1 therapy Review existing vendor capabilities before adding additional point solutions Contract with vendors to drive outcomes while examining overall program costs The report identifies three critical phases where these solutions can support employers in managing their GLP-1 coverage: Initiation: Providing targeted GLP-1 coverage using clinical criteria, behavioral or AI-based screening, narrow prescribing networks, or step-therapy pathways that include lower-cost alternatives or lifestyle change programs
Be cautious if you have cancer
We will cover that in detail later in the peptide vial section of this guide
Three concentration options are available
CookUnity Business | Recipe created on: 6/8/2026 How Self-Insured Employers Are Managing the Cost of GLP-1 Coverage Learn how self-insured employers are managing rising GLP-1 drug costs with structured coverage policies, nutrition programs, and population health strategies